1.Treatment of hepatocellular carcinoma with tumor thrombus of the portal vein:a report of 15 cases
Wei LU ; Zeming HU ; Yuanlong YU ; Xiaojian CHANG
Chinese Journal of General Surgery 1993;0(03):-
Objective To evaluate the effect of combination of surgery and transcatheter hepatic arterial chemotherapic embolism(THACE) with or without placement of drug deliery system(DDS) of portal vein for hepatocellular carcinoma with portal vein tumor thrombus (PVTT). Methods Fifteen cases of advanced HCC with PVTT were treated by hepatectomy, thrombectomy of portal vein with THACE,and 5 of the 15 cases received postoperative chemotherapy via portal vein. Results All patients survived after operation. The survival rate of 6,12,18 months was 15,12 and 9 cases respectively. Conclusions Operation is still an effective method for advanced HCC , postoperative comprehensive treatment can improve the survival rate.
2.Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.
Jiaming SU ; Yi SUI ; Jian DING ; Fuqiang LI ; Shuang SHEN ; Yang YANG ; Zeming LU ; Fei WANG ; Lingling CAO ; Xiaoxia LIU ; Jingji JIN ; Yong CAI
Protein & Cell 2016;7(10):749-760
The BCCIP (BRCA2- and CDKN1A-interacting protein) is an important cofactor for BRCA2 in tumor suppression. Although the low expression of BCCIP is observed in multiple clinically diagnosed primary tumor tissues such as ovarian cancer, renal cell carcinoma and colorectal carcinoma, the mechanism of how BCCIP is regulated in cells is still unclear. The human INO80/YY1 chromatin remodeling complex composed of 15 subunits catalyzes ATP-dependent sliding of nucleosomes along DNA. Here, we first report that BCCIP is a novel target gene of the INO80/YY1 complex by presenting a series of experimental evidence. Gene expression studies combined with siRNA knockdown data locked candidate genes including BCCIP of the INO80/YY1 complex. Silencing or over-expressing the subunits of the INO80/YY1 complex regulates the expression level of BCCIP both in mRNA and proteins in cells. Also, the functions of INO80/YY1 complex in regulating the transactivation of BCCIP were confirmed by luciferase reporter assays. Chromatin immunoprecipitation (ChIP) experiments clarify the enrichment of INO80 and YY1 at +0.17 kb downstream of the BCCIP transcriptional start site. However, this enrichment is significantly inhibited by either knocking down INO80 or YY1, suggesting the existence of both INO80 and YY1 is required for recruiting the INO80/YY1 complex to BCCIP promoter region. Our findings strongly indicate that BCCIP is a potential target gene of the INO80/YY1 complex.
Calcium-Binding Proteins
;
genetics
;
metabolism
;
Cell Cycle Proteins
;
genetics
;
metabolism
;
Chromatin Assembly and Disassembly
;
physiology
;
DNA Helicases
;
genetics
;
metabolism
;
HeLa Cells
;
Humans
;
Multiprotein Complexes
;
genetics
;
metabolism
;
Nuclear Proteins
;
genetics
;
metabolism
;
Promoter Regions, Genetic
;
physiology
;
Transcription, Genetic
;
physiology
;
YY1 Transcription Factor
;
genetics
;
metabolism